価格表

在庫・価格 : 2025年07月02日 01時49分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-ERCC1, Mouse-Mono(4F9), UltraMAB
データシート
UM500008 ORIオリジーン テクノロジーズ
OriGene Technologies, Inc.
100 μl ¥204,000
(未発注)
追加

在庫・価格 : 2025年07月02日 01時49分 現在

Anti-ERCC1, Mouse-Mono(4F9), UltraMAB

  • 商品コード:UM500008
  • メーカー:ORI
  • 包装:100μl
  • 価格: ¥204,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Ma D et al. Using protein microarray technology to screen anti-ERCC1 monoclonal antibodies for specificity and applications in pathology. BMC Biotechnol. 2012;12:88
Ma D et al
2012/01/01
Species: Human PubMed
2 Smith DH et al. Measuring ERCC1 protein expression in cancer specimens: validation of a novel antibody. Sci Rep 2014;4:4313
Smith DH et al
2014/01/01
PubMed
3 J E Bauman, M C Austin, R Schmidt, B F Kurland, A Vaezi, D N Hayes, E Mendez, U Parvathaneni, X Chai, S Sampath, and R G MartinsBritish Journal of Cancer 109, 2096-2105 (15 October 2013)

PubMed
4 Bauman JE et al. ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial. Br. J. Cancer 2013 Oct;109(8):2096-105
Bauman JE et al
2013/01/01
PubMed
5 Bahamon BN et al. Development and Validation of an ERCC1 Immunohistochemistry Assay for Solid Tumors. Arch. Pathol. Lab. Med. 2016 Dec;140(12):1397-1403
Bahamon BN et al
2016/01/01
PubMed
6 Laufs V et al. ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas. Eur. J. Endocrinol. 2018 Feb;178(2):183-190
Laufs V et al
2018/01/01
PubMed
7 Kuo MS et al. A novel antibody-based approach to detect the functional ERCC1-202 isoform. DNA Repair (Amst.) 2018 04;64:34-44
Kuo MS et al
2018/01/01
PubMed
  • No.: 1
  • 文献情報:
    Ma D et al. Using protein microarray technology to screen anti-ERCC1 monoclonal antibodies for specificity and applications in pathology. BMC Biotechnol. 2012;12:88
    Ma D et al
    2012/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Smith DH et al. Measuring ERCC1 protein expression in cancer specimens: validation of a novel antibody. Sci Rep 2014;4:4313
    Smith DH et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    J E Bauman, M C Austin, R Schmidt, B F Kurland, A Vaezi, D N Hayes, E Mendez, U Parvathaneni, X Chai, S Sampath, and R G MartinsBritish Journal of Cancer 109, 2096-2105 (15 October 2013)

  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Bauman JE et al. ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial. Br. J. Cancer 2013 Oct;109(8):2096-105
    Bauman JE et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Bahamon BN et al. Development and Validation of an ERCC1 Immunohistochemistry Assay for Solid Tumors. Arch. Pathol. Lab. Med. 2016 Dec;140(12):1397-1403
    Bahamon BN et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Laufs V et al. ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas. Eur. J. Endocrinol. 2018 Feb;178(2):183-190
    Laufs V et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Kuo MS et al. A novel antibody-based approach to detect the functional ERCC1-202 isoform. DNA Repair (Amst.) 2018 04;64:34-44
    Kuo MS et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed